Upload EMIS CSV
Select your ICB region first, then upload your EMIS Population Reporting CSV. Ensure your search exports all mapped columns.
Clinical Alerts
Local Parameters
Please select an ICB region on the left to view its active clinical parameters.
Clinical Disclaimer: Drug Interactions
Class-Level Flags: Interaction flags in Column R represent broad drug classes and must be verified by a clinical pharmacist against the BNF.
1. Additive Bleed Risk: Antiplatelets (Aspirin, Clopidogrel), NSAIDs (Ibuprofen, Naproxen), SSRIs/SNRIs & Steroids impair haemostasis → triggers Bleeding Risk SMS template in Clinical Notes.
2. Increased DOAC Plasma Levels: CYP3A4/P-gp inhibitors (Amiodarone, Diltiazem/Adizem, Verapamil, Clarithromycin, Azoles) slow clearance → increases bleeding risk; review dose/monitoring & triggers Bleeding Risk SMS template.
3. Enzyme Inducers (Thrombosis Risk): Carbamazepine, Phenytoin, Rifampicin & St John's Wort accelerate clearance → high risk of DOAC failure / clot. Bleeding SMS is suppressed; urgent prescriber review required.
Information Governance & Data Handling
Patient data stays on this device. This tool runs entirely inside your browser in memory only — it is
never uploaded, transmitted, or sent to any server.
The application makes no external network connections. Nothing is saved or stored: patient data is cleared as soon as you close or refresh the tab.
Your responsibilities: only run this tool on an approved NHS device in line with your organisation's policies.
Your responsibilities: only run this tool on an approved NHS device in line with your organisation's policies.
Technical Reference: EMIS Layout
Developer Access Required
Clinical Limitations & Exclusions
Important context for clinical governance:
• Child-Pugh Score: Flags elevated ALT/Bili but does not calculate Child-Pugh score for severe hepatic disease.
• Medication Adherence: Checks if DOAC is on repeat, but does not analyse issue dates to confirm compliance.
• OTC / Herbals: Only flags drugs in Column R. Cannot detect unprescribed OTC NSAIDs or St John's Wort.
• Risk Scores: Does not calculate or monitor HAS-BLED, ORBIT, or CHA2DS2-VASc scores.
• Recent Acute Events: Does not screen for recent GI bleeds, planned surgeries, or acute AKI between bloods.
• Contraindications: Does not check for pregnancy or breastfeeding status.
Proprietary Clinical Software & Licensing Agreement
© 2026 Pharmatopia.co.uk. All rights reserved.
1. Intellectual Property & Copyright Notice
The Pharmatopia DOAC Recall Application (DRA), including its underlying clinical engines, validation matrices, alert algorithms, user interface architecture, and export schemas, is the proprietary intellectual property of Pharmatopia.co.uk. No part of this application may be copied, reproduced, reverse-engineered, decompiled, distributed, adapted, or hosted without prior written authorisation from Pharmatopia.co.uk.
2. Clinical Governance & Algorithmic Integrity
The clinical logic, dose calculation matrices, and safety parameters within this software have been verified against published ICB and NICE guidelines. Any extraction, unapproved modification, or running of this logic outside Pharmatopia.co.uk immediately compromises algorithmic integrity, voids all clinical verification, and constitutes unverified clinical decision support, creating severe medical negligence risk for the operator.
3. Indemnity & Practice Responsibility
Authorised use is strictly limited to contracted NHS organisations and registered GP practices under valid licensing agreements. Any unauthorised duplication, scraping, or running of extracted code outside Pharmatopia’s managed infrastructure transfers 100% of clinical, legal, and vicarious liability for adverse patient events, missed recalls, or dosing errors directly to the individual practitioner and employing GP practice/PCN.
Administrative Recall & Workflow Tool Notice:
The DOAC Recall Application (DRA) is an administrative workflow and recall coordination tool designed to assist primary care teams in scheduling routine monitoring against established ICB guidelines. It is not a medical device and does not provide clinical diagnoses, prescribe treatment, or replace professional clinical judgement. All dose evaluations, laboratory interpretations, and treatment decisions remain the sole clinical responsibility of the reviewing registered healthcare professional.